121 related articles for article (PubMed ID: 12038967)
21. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
Bin Z; Kun L
Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
[TBL] [Abstract][Full Text] [Related]
22. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus.
Antonopoulou S; Fragopoulou E; Karantonis HC; Mitsou E; Sitara M; Rementzis J; Mourelatos A; Ginis A; Phenekos C
J Med Food; 2006; 9(3):356-62. PubMed ID: 17004898
[TBL] [Abstract][Full Text] [Related]
23. Structural Elucidation of Irish Ale Bioactive Polar Lipids with Antithrombotic Properties.
Tsoupras A; Lordan R; O'Keefe E; Shiels K; Saha SK; Zabetakis I
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708453
[TBL] [Abstract][Full Text] [Related]
24. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol.
Lekka M; Tokumura A; Tsuji H; Hanahan DJ
Arch Biochem Biophys; 1993 May; 302(2):380-4. PubMed ID: 8489242
[TBL] [Abstract][Full Text] [Related]
25. High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography.
White T; Bursten S; Federighi D; Lewis RA; Nudelman E
Anal Biochem; 1998 Apr; 258(1):109-17. PubMed ID: 9527856
[TBL] [Abstract][Full Text] [Related]
26. Free radical oxidation of plasmalogen glycerophosphocholine containing esterified docosahexaenoic acid: structure determination by mass spectrometry.
Zemski Berry KA; Murphy RC
Antioxid Redox Signal; 2005; 7(1-2):157-69. PubMed ID: 15650405
[TBL] [Abstract][Full Text] [Related]
27. Isolation and identification of embryo-derived platelet-activating factor in mice.
Kodama H; Muto H; Maki M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):899-906. PubMed ID: 2794622
[TBL] [Abstract][Full Text] [Related]
28. Plasma lipid analysis by hydrophilic interaction liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Sonomura K; Kudoh S; Sato TA; Matsuda F
J Sep Sci; 2015 Jun; 38(12):2033-7. PubMed ID: 25845351
[TBL] [Abstract][Full Text] [Related]
29. Molecular species of phospholipids of interleukin-2-dependent murine cytotoxic T lymphocytes.
Nishihira J; Ishibashi T; Sawamura Y; Hosokawa M
Biochem Mol Biol Int; 1995 Apr; 35(5):1017-27. PubMed ID: 7549919
[TBL] [Abstract][Full Text] [Related]
30. Anti-Inflammatory and Anti-Platelet Properties of Lipid Bioactives from Apple Cider By-Products.
Tsoupras A; Moran D; Byrne T; Ryan J; Barrett L; Traas C; Zabetakis I
Molecules; 2021 May; 26(10):. PubMed ID: 34066136
[TBL] [Abstract][Full Text] [Related]
31. Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species.
Petkovic M; Schiller J; Müller M; Benard S; Reichl S; Arnold K; Arnhold J
Anal Biochem; 2001 Feb; 289(2):202-16. PubMed ID: 11161314
[TBL] [Abstract][Full Text] [Related]
32. Regiospecific analysis of neutral ether lipids by liquid chromatography/electrospray ionization/single quadrupole mass spectrometry: validation with synthetic compounds.
Hartvigsen K; Ravandi A; Bukhave K; Hølmer G; Kuksis A
J Mass Spectrom; 2001 Oct; 36(10):1116-24. PubMed ID: 11747105
[TBL] [Abstract][Full Text] [Related]
33. Structural elucidation of olive pomace fed sea bass (Dicentrarchus labrax) polar lipids with cardioprotective activities.
Nasopoulou C; Smith T; Detopoulou M; Tsikrika C; Papaharisis L; Barkas D; Zabetakis I
Food Chem; 2014 Feb; 145():1097-105. PubMed ID: 24128590
[TBL] [Abstract][Full Text] [Related]
34. An improved SPE method for fractionation and identification of phospholipids.
Fauland A; Trötzmüller M; Eberl A; Afiuni-Zadeh S; Köfeler H; Guo X; Lankmayr E
J Sep Sci; 2013 Feb; 36(4):744-51. PubMed ID: 23349108
[TBL] [Abstract][Full Text] [Related]
35. [PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships].
Kertscher HP; Ostermann G
Pharmazie; 1991 Oct; 46(10):708-11. PubMed ID: 1803385
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke.
Satoh K; Imaizumi T; Yoshida H; Hiramoto M; Takamatsu S
Acta Neurol Scand; 1992 Feb; 85(2):122-7. PubMed ID: 1574985
[TBL] [Abstract][Full Text] [Related]
37. Platelet activating factor: an inhibitor of neutrophil activation?
O'Donnell MC; Siegel JN; Fiedel BA
Clin Exp Immunol; 1981 Jan; 43(1):135-42. PubMed ID: 7249391
[TBL] [Abstract][Full Text] [Related]
38. Immunological mechanisms of human platelet involvement.
Camussi G; Tetta C; Segoloni G; Vercellone A
Ric Clin Lab; 1978; 8(4):262-72. PubMed ID: 734319
[TBL] [Abstract][Full Text] [Related]
39. Formation of PAF-like compounds by peroxidation of phospholipids from bovine brain.
Tokumura A; Tanaka T; Yotsumoto T; Tsukatani H
J Lipid Mediat; 1992; 5(2):127-30. PubMed ID: 1525352
[TBL] [Abstract][Full Text] [Related]
40. Characterization and change of phospholipids in the aorta of Watanabe hereditable hyperlipidemic rabbit.
Hara A; Taketomi T
Jpn J Exp Med; 1990 Dec; 60(6):311-8. PubMed ID: 2096224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
